Journal of Applied Pharmacy
Open Access

Qualitative Studies on Anti-diabetic Activity of Corchorus depressus

Irum Latif¹, Riffat Latif^2*, Iftikhar Khan³, Maida Minahil Mushtaq⁴, Muhammad Zubair³, Qurat-ul Ain² and Rizwan Khalid^{4 *}Correspondence: Riffat Latif, Department of Pharmaceutical Sciences, The Ripah International University, Lahore, Pakistan, Email:

Author info »

Introduction

Diabetes mellitus is an epidemic disease all over the world. It is a metabolic disease that results in chronic hyperglycemia due to damage of pancreatic β-cells, lack of insulin secretion, insulin action or both [1]. The diabetes causing factors includes obesity, energy rich diet, sedentary lifestyle, blurred vision, frequent urination, sudden weight loss, increased thirst, hunger and sometimes fatigue [2]. Diabetes mellitus prevalence is increasing day by day and will be expected to increase by 5.4% in 2025 [3].

Corchorus depressus Linn., locally known as “Baphuli”, belonging to family Tiliaceae is mostly found in Pakistan, Arabia, India, Afghanistan. Pain, fever, gonorrhea, treachery troubles, general weakness, diabetes, gastric diseases, sexual dysfunction can be treated by it [4].

Hence, folklore importance of Corchorus depressus Linn., has prompted us to scientifically investigate its potential for diabetes and anti-urease activities. Our aim wasto develop scientific basis for the traditional ethnobotanical uses of Cholistani plants for diabetes, for the evaluation of anti-hyperglycemic effects of selected plant on animals and to check the anti-diabetic and anti-urease seasonal variations of various extracts and fractions of this plant in three different seasons (September 2015, January 2016 and May 2016).

From an extensive literature search it was observed that, no work has been reported in perspective of diabetes and anti-urease activities of this plant. However, C. olitorius and C. capsularis showed better anti-diabetic and anti-inflammatory activities Certain biological activities of this genus includes anti-fungal, analgesic, anti-bacterial and anti-pyretic ACE, anti-malarial, anti-anthelmintic [5]. Jute was reported for aging resistance of bio-epoxy jute-basalt hybrid composites as novel multi-layer structures for cladding [6] (Figure 1).

Figure 1: GC-MS analysis.

Materials and Methods

The chemicals used in this research were purchased from different sources, i.e. Alloxan was purchased from Acros Organics (USA), sodium chloride, sodium hydroxide, citric acid monohydrate, potassium hydroxide, benzene, ether, sulphuric acid, hydrochloric acid, chloroform, ethanol and methanol were all of analytical grade and were purchased from Merck (Germany).

Acarbose, thiourea, PNPG, methanol, ethanol, pet ether, dichloromethane, pyridine, ethyl-acetate, chloroform, diethyl amine were purchased from Sigma-Aldrich, Merk and Flukacompanies. NaOH, Na₂CO₃, HCl, Na₂PO₄, KH₂PO₄, DMSO were of analytical grade.

Instrumentation

The instruments used were rotary evaporator heating bath, recirculating chiller and pump (Buchi), vacuum pump, spectrophotometer (Shimadzo, Japan), HT Bio, EZTek96microplate reader, EZ-Fit Enzyme Kinetics software (Perrella Scientific Inc. Amherst, USA), Power Lab data acquisition system (AD instruments, Sydney, Australia) and Glucometer (Accu-check performa, Roche, Germany). Vortex mixture of HeidolphReax Top was used to make dilutions and to dissolve the crude extracts. The glassware used was made of pyrex. Shimadzuanalytical weighing balance was used to weigh the amount in milli-grams.

Plant collection and extraction

The whole plant of Corchorus depressus Linn. 20.5 kg along with roots had been collected from ChakLehaar on 14^th May, 2018, Punjab, Pakistan. The plant specimen had been identified by Taxonomist, Mr. Muhammad Waris, Cholistan Institute of Desert Studies (CIDS), The Islamia University of Bahawalpur, Pakistan. The plant specimen (Voucher No.3473/CIDS/IUB) had been stored in the herbarium of CIDS for future reference.

After all, the plant was dried and marcerated in 20 lit of methanol for one week, the filtrate was evaporated, under high vacuum in a rotary evaporator to get 81 g crude methanolic extract of C. depressus Linn.

Biological activities

In vitro α-glucosidase inhibition activity: α-Glucosidase assay was carried out with slight modification as performed by Fiore V, et al. [7]. The assay contained 50 mM phosphate buffer pH 6.8 (70 μl), 0.5 mM test compound (10 μl), enzyme solution 0.02 Units (10 μl) to make a total volume of 100 μl. 10 μl of substrate PNPG was used to start the reaction. All the contents had been mixed up properly, pre-incubated for 10 minutes at 370C and pre reading was taken at 400 nm. Yellow colour absorbance took place indicates the formation of p-Nitrophenol. Epoch (Bio Tek, USA) 96-well microplate reader was used to calculate the absorbance at 400 nm. Acarbose was used as a positive control. The experiments had been carried out in triplicates.

The fractions CD-1 to CD-24 were subjected to α-glucosidase inhibition assay. Acarbose was used as a control with IC₅₀ value 37.38 ± 0.12 μM.

Effects of seasonal variations on anti-urease inhibition activity of C. depressus Linn: The plant C. depressus was collected in three different periods (September 2015, January, 2016 and May, 2016). The 50 g of the plant material of all the periods was soaked in 250 ml n-hexane for 3 days, separately. The extraction was carried out 3 times. All of the filtrates were evaporated in a rotary evaporator under high vacuum to get crude hexane extracts named as CD-M1 0.51 g (hexane extract of C. depressus May, 2016), CD-S2 0.52 g (hexane extract of C. depressus September 2015) and CD-J3 0.50 g (hexane extract of C. depressus January, 2016.

The residual plant material was again soaked in 250 ml methanol. The extraction was carried out 3 times to get crude metanolic extracts named as CD-M4 3.16 g (methanolic extract of C. depressus May, 2016), CD-S5 3.8 g (methanolic extract of C. depressus September 2015) and CDJ6 2.5 g (methanolic extract of C. depressus January, 2016.

Similarly, the residual plant material was again soaked in 250 ml water. The extraction was carried out 3 times. All of the filtrate was evaporated in a rotary evaporator under high vacuum, for complete dryness the temperature was increased to 60°C to get crude water extracts named as CD-M7 1.04 g (methanolic extract of C. depressus May, 2016), CD-S8 0.89 g (methanolic extract of C. depressus September 2015) and CD-J9 0.94 g (methanolic extract of C. depressus January, 2016. Then these hexane, methanolic and water extracts were subjected to α-glucosidase inhibition activity.

The extracts CD-M1 to CD-J9 as given in Table 2 were subjected to α-glucosidase inhibition assay. Acarbose was used as a control with IC₅₀ value 37.38 ± 0.14 μM. The CD-J3, CD-S2 and CD-M1 hexane extracts showed potent remarkable results with IC₅₀ values 8.43 ± 0.12, 26.53 ± 0.15 and 37.28 ±0.16 μg/mL respectively.

Table 1: GC-MS analysis of fraction CDB.

Table 2: Effect of seasonal variations on α-glucosidase inhibitory activity of C. depressus.

In vitro anti-urease inhibition activity: The 20 mL urease enzyme and 6 mL of phosphate buffer was added in it. Both the contents were mixed up properly and placed in the wells of plates, preincubated for 10 minutes at 25°C and test compound 5 mL was added in it. This solution was again incubated for 10 minutes at 25°C and 20 mM urea 15 mL was added. This mixture was again incubated for 10 minutes at 25°C and RGI 2 (100 ml) was added in it and incubated for 25 minutes at room temperature. Gen 5 software was used on ELISA reader for measuring the absorbance at 630 nm. EZ-Fit enzyme kinetics software (Perrella Scientific Inc.,

Amherst, MA., USA) was used for calculating the IC₅₀ values of the fractions. The percentage of inhibition was calculated by using the following formulae [8,9].

The fractions CD-1 to CD-24 were subjected to anti-urease inhibition assay. Thiourea was used as a control. None of the fraction showed potent IC₅₀ values. CD1 was the pure compound named dioctyl phthalate.

‘This study suggests that is prudent to adjust the screen brightness than needed to do the work or enjoy the entertainment.

In vivo α-glucosidase activity of Corchorus depressus Linn: Both sexes of Albino Sprague-Dawley rats that weighed 200-250 gm of body weight were selected and kept in the animal room of Pharmacology Research Laboratory at the Faculty of Pharmacy and Alternative Medicines, the Islamia University of Bahawalpur. The animals were housed in polycarbonated cages of size 47 × 34 × 18 cm³ with maximum of three animals per cage. The standard conditions of temperature and humidity that were maintained throughout the study were (25 ± 2°C) and (55-55%) along with exposure to a 12:12 hours light and dark cycle,throughout. Animals had been supplied with a normal animal diet and allowed to drink water ad libitum. Animals had been familiarized with the experimental conditions for one week before the start of study to minimize animal stress. The study protocols and procedures had been approved by the ethics committee of animal handling of the department of pharmacy, the Islamia University of Bahawalpur.

Induction of diabetes mellitus: Diabetes mellitus had been induced pharmacologically using Alloxan monohydrate. Alloxan selectively inhibited glucose induced insulin secretion by inhibiting the glucokinase and caused a state of insulin dependent diabetes mellitus (type-1) through its ability to induce a selective necrosis of the β cells of pancreas [10]. Alloxan can be administered intravenously (65 mg/kg) but an intraperitoneal dose below 150 mg/kg may be insufficient for the induction diabetes in rats.

Drug administration: After application of alloxan blood glucose at fifth day of initial dose committed the presence of disease (DM), animals were allowed to stabilize for one week. On the day seventh, animals were divided into different groups and their fasting blood glucose levels was determined. The treatment was started on the same day and was considered the day one of the study Lasker K, et al. [11] and Lenzen S [12]. Furthermore estimation of fasting blood glucose level was carried out on 1st and 4th days of the study as given.

Assay for determination of blood glucose level: Blood glucose level was determined using a single touch glucometer (Accu- chek Performa, Roche, Germany) with test strips capable of measuring blood glucose level in the range of 10 mg/dL to 600 mg/dL. Test strips used for blood glucose estimation contains test area that is incorporated within chemicals which are highly sensitive. When blood comes in contact with this sensitive area, a chemical reaction starts that is designated as glucose dye oxidoreductase mediator reaction (PQQ-dependent glucose dehydrogenase mediator reaction). The consequence of this reaction is change in color of test strip area. The meter is designed to detect this change quantitatively and convert this change into blood glucose level.

Calculations and statistical examination

The percentage inhibition was calculated by the following equation.

Inhibition (%)=(Abs. of Control–Abs. of Test/Abs. of Control 100

The fractions CD-1 to CD-14 were subjected to α-glucosidase inhibition assay and their IC₅₀ values were determined by using EZ-Fit enzyme kinetics (Perrella Scientific Inc, Amherst, USA) software. Test solutions were assayed at various dilutions e.g. 0.5, 0.25, 0.125 and 0.0625 mg/ml. All the results were mean ± SEM and n=5. Student t test was used. P values are considered as P < 0.05=significant (*), P < 0.01=more significant (**) and P < 0.001=highly significant (***). All extract treated groups and standard controlled were compared to positive control and positive control was compared to normal control.

Phytochemical investigation

Phytochemical investigation was carried out with the help of GCMS and LC-MS analysis.

The fraction CDB (10% EtOAc/Pet. ether) was subjected to GCMS and 22 metabolites were isolated.

Based on LCMS analysis and α-glucosidase inhibitory profile, it is augmented that betulinic acid, canarigenin and strophanthidin might be the potent biological markers for anti-diabetic activity. Detailed studies needed to be done to further confirm this assumption. The structures cannot be assigned to the rest of the peaks.

Results and Discussion

For the confirmation of traditional antidiabetic use, the fractions CD-2 to CD-24 of crude methanolic extract of Corchorusdepressuswere tested for in vitro α-glucosidase activity. The fractions CD-14 CDB (10% EtOAc/Pet. Ether), CD-2 CDC (10% EtOAc/Pet. Ether), CD-3 CDD (10% EtOAc/Pet. Ether), CD-4 CDE (10% EtOAc/Pet. Ether), CD-5 CDF (20% EtOAc/ Pet. Ether), CD-7 CDG (30% EtOAc/Pet. Ether), CD-8 CDH (40% EtOAc/Pet. Ether), CD-9 CDI (50% EtOAc/Pet. Ether), CD- 10 CDJ (50% EtOAc/Pet. Ether), CD-12 CDK (50% EtOAc/Pet. Ether), CD-13 CDA obtained by eluting column at 16% EtOAc/ Pet Ether, CD-15 CDL (70% EtOAc/Pet. Ether), CD-16 CDM (90% EtOAc/Pet. Ether), CD-17 CDN (100% EtOAc), CD-18 CDO (10% MeOH/EtOAc), CD-19 CDQ (20% MeOH/EtOAc), CD-24 CDR (100% MeOH) respectively. The fractions CD-2, CD- 3, CD-5, CD-6, CD-7, CD-13, CD-14, CD-15, CD-16, CD-17 and CD-20 showed inhibition against α-glucosidasewith IC₅₀ values 13.16 ± 0.09, 31.54 ± 0.05, 45.32 ± 0.12, 12.75 ± 0.07, 46.24 ± 0.09, 38.12 ± 0.06, 4.31 ± 0.07, 6.32 ± 0.08, 15.37 ± 0.13, 23.75 ± 0.1, 12.42 ± 0.13 and 27.65 ± 0.17 μg/mL respectively as compared to acarbose with IC₅₀ 37.38 ± 0.12 μM.

The fractions CD-2 to CD-24 of crude methanolic extract of Corchorus depressus were tested for in vitro anti-urease activity and their IC₅₀ values were determined. Almost all the fractions found to be inactive for anti-urease assay as given in Table 3. Thiourea was used as a control. None of the fraction showed potent IC₅₀ values. CD-1 was the pure compound named dioctyl phthalate.

Table 3: Anti-urease inhibition of various fractions of methanolic extract of Corchorus depressus Linn.

The crude methanolic extract of Corchorus depressus was also tested for in vivo anti-diabetic activity (Table 4). The crude methanolic extract of plant was dissolved in normal saline and was inserted intraperitoneally in alloxan induced diabetic rats at doses of 50, 75 and 100 mg/kg. At the beginning, blood glucose level was 104 ± 2.9 mg/dL for normal control group, 476.7 ± 4.0 mg/dL was the blood glucose value of positive control group and 478 ± 6.2 mg/ dL was the glucose level of standard control group. Glucose level of crude methanolic extract of C. depressus at 50, 75 and 100 mg/ kg group was observed 467.5 ± 14.5, 469.5 ± 2.5, 479.5 ± 5.2 mg/ dL, respectively.

Table 4: α-Glucosidase inhibition of various fractions of methanolic extract of Corchorusdepressus Linn.

On the first day, 107.1 ± 2.1 mg/dL was glucose level of normal control group, 485.9 ± 3.1 mg/dL and 90.8 ± 6.6 mg/dL was the value of observed blood glucose of standard control group, 290.0 ± 20.0 mg/dL was reduced value of blood glucose for crude extract of C. depressus 50 mg/kg group, 149.0 ± 4.0 mg/dL was observed value for 75 mg/kg and 115.8 ± 6.4 mg/dL was observed blood glucose value for 100 mg/kg group. On fourth day, 109 ± 1.3 mg/dL was observed value for standard control group, 106.5 ± 4.1 mg/dL was measured value for standard control group, 208.5 ± 3.5 mg/dL was the calculated amount of blood glucose for C. depressus 50 mg/kg whereas 129.5 ± 7.5 mg/dL was blood glucose level observed for 75 mg/kg and 106.0 ± 2.2 mg/dL was blood glucose level observed for 100 mg/kg of concentration. Results of crude extracts of C. depressus at 100 mg/kg were more significant as compared to 75 and 50 mg/kg. It was observed that the dose dependent anti-diabetic activity portrait of C. depressus was observed to be similar to the standard drug, glibenclamide.

Table 5 showed the values with reduction in blood glucose level. In this profile, alloxan was used to induced diabetes mellits. Alloxan inhibited the glucokinase and inhibits glucose, a state of insulin dependent diabetes mellitus (IDDM) by discerning necrosis of β-cells of pancreas [13-20].

Table 5: Effects of intra-peritoneal administration of different doses of C. depressus Linn. Inalloxan induced diabetic rats for 4 days.

The fraction CDB (10% EtOAc/Pet. ether) showed remarkable α-glucosidase activity with IC₅₀ 6.32 ± 0.08 μg/mL. So it was sent for GC-MS analysis. The GC-MS analysis of sub-fraction CDB (0.054 g) was done and 22 compounds were isolated which belongs to hydrocarbons, heterocyclics, monocyclic terpenoids and phthalate class of compounds.

Moreover LCMS analysis of fractions CD-23, CD-22, CD-21, CD- 20 and CD-13 was done. The fraction CD-23 (10% EtOAc/Pet. ether) showed the presence of strophanthidin, fraction CD-21 CDE (10% EtOAc in Pet. ether) also resulted in strophanthidin. However, CD-22 CDF (20% EtOAc in Pet. Ether) the structure of not any compound was determined from this fraction, CD-20 CDG (30% EtOAc/Pet. ether) results in the isolation of iso-rhamnetin, strophanthidin, β-sitosterol and fraction CD-13 (16% EtOAc/Pet. ether) resulted in canarigenin and betulinic acid, respectively. The structures cannot be assigned to the rest of the peaks.

Based on LCMS analysis and α-glucosidase inhibitory profile, it is augmented that betulinic acid, canarigenin and strophanthidin might be the potent biological markers for anti-diabetic activity. Detailed studies needed to be done to further confirm this assumption (Figure 2) ( Table 6-10) [20-24].

Figure 2: Anti-diabetic activity of Corchorus depressus.

Conclusion

Based on experimental data, it was concluded that crude extract of C. depressus has good anti-diabetic potential. The methanolic extract and its various fractions in pet ether and ethyl-acetate showed remarkable inhibitory activities against α-glucosidase. Fractions CD-2, CD-3, CD-4, CD-5, CD-6, CD-7, CD-13, CD-14, CD-15, CD-16, CD-17 and CD-20 showed inhibition against α-glucosidase with IC₅₀ values 13.16 ± 0.09, 31.54 ± 0.05, 45.32 ± 0.12, 12.75 ± 0.07, 46.24 ± 0.09, 38.12 ± 0.06, 4.31 ± 0.07, 6.32 ± 0.08, 15.37 ± 0.13, 23.75 ± 0.1, 12.42 ± 0.13 and 27.65 ± 0.17μg/mL, respectively, as compared to acarbose with IC₅₀ 37.38 ± 0.12 μM.

The GC-MS analysis of CD-14 CDB results in the isolation of phytochemicals as given. The LC-MS analysis of the fractions CD- 23, CD-22, CD-21, CD-20 and CD-13 gave rise to strophanthidin, iso-rhamnetin, β-sitosterol, canarigenin and betulinic acid respectively. Strophanthidin was observed in CD-23, CD-21 and CD-20 respectively. So it can be served as potent marker for α-glucosidase inhibitor. None of the phytochemical was similar in GC-MS and LC-MS analysis. But these non-polar fractions were inactive for anti-urease activity.

Table 6: LC-MS analysis of fraction CD-23.

Table 7: LC-MS analysis of fraction CD-23.

Table 8: LC-MS results of fraction CD-21.

Table 9: LC-MS results of fraction CD-20.

Table 10: LCMS results of fraction CD-13.

The CD-J3, CD-S2 and CD-M1 hexane extracts showed potent remarkable results with IC₅₀ values 8.43 ± 0.12, 26.53 ± 0.15 and 37.28 ± 0.16 μg/mL respectively.

The extracts CD-M7 and CD-J9, May and January water extracts of C. depressus showed best anti-urease activities with IC₅₀ 1.63 ± 0.08 and 2.42 ± 0.07 μg/mL, as compared to thiourea with IC₅₀ 21.46 ± 0.13 μM respectively.

So it was concluded from the above discussion that non-polar CD fractions (upto 20% EtOAc/Pet. ether) showed potent IC₅₀ values for α-glucosidase inhibition but CD polar (water extracts) showed remarkable IC₅₀ values for anti-urease inhibition.

Dioctyl phthalate 791.6 mg from fraction CDA and CDF toxicity was checked on animal model. Rats were dyeing on high dose 100 mg/kg of phthalate injection. DOP was confirmed by co TLC by using analytical grade solvent is little toxic to this plant. If we remove phthalate from this plant, it will be more effective for curing diabetes.

References

1. Ahmad VU, Ali A, Ali Z, Zafar FN, Zahid M. Novel cycloartanesaponins from C. depressus Linn. Chem Pharm Bull. 2000;48:1597-1601.
2. Akhter R, Arshad M. Arid rangelands in the Cholistan desert, Pakistan. Science et Changements Planetaires/Secheresse. 2006;17:210-217.
3. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care. 1997;20:518-520.
4. Arshad M, Hassan A, Ashraf MY, Noureen S, Moazzam M. Edephic factors and distribution of vegetation in the Cholistan desert, Pakistan. Pak J Bot. 2008;40:1923-1931.
5. Bamigboye JT, Grace OT, Olujide OO, Amos AF. Polyphenolic compounds with anti-tumor potential from Corchorus olitorius L. Tiliaceae: A Nigerian leaf vegetable. Bioorg Med Chem Lett. 2016;26:3404-3410.
6. El-Demerdash F, Yousef M, El-Naga N. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem Toxicol. 2005;43:57-63.
7. Fiore V, Scalici T, Badagliacco D, Enea D, Alaimo G, Valenza A. Aging resistance of bio-epoxy jute-basalt hybrid composites as novel multilayer structures for cladding. Composite Structures. 2017;160:1319-1328.
8. Harsh ML, Nag TN. Flavonoids with anti-microbial activities of arid zone plants. Geobios. 1988;15:32-35.
9. Jun W, Jun K, Hideyuki K, Ryoya N. Isolation and identification of α-glucosidase inhibitors from Tochu-cha (Eucommia ulmoides). Biosci Biotechnol Biochem. 1997;61:177-178.
10. Khan MSY, Shamsi MA. Chemical investigation of C. depressus Linn. Part of the Ph.D thesis of M. A. S, Aligarh Muslim University, Aligarh, India. 1980.
11. Lasker K, Forster F, Bohn S, Walzthoeni T, Villa E, Unverdorben P, et al. Molecular architecture of 26S proteasome holocomplex determined by an integrative approach. Proceedings of the National Academy of Sciences. 2012;109:1380-1387.
12. Lenzen S. The mechanism of alloxan and Streptozotocin induced diabetes. Diabetologia. 2008;51:216-226.
13. Mansour HA, Newairy ASA, Yousef MI, Sheweita SA. Biochemical study on the effects of Egyptian herbs in alloxan-induced diabetic rats. Toxicol. 2002;170:221-228.
14. Moller DE, Flier JS. Insulin resistance: Mechanisms syndromes and implications. N Eng J Med. 1991;325:938-948.
15. Muhammad IT, Naheed R, Mamona N, Shabir A, Muhammad S, Abdul J, et al. Anti-urease secondary metabolites from Seriphidium quettense. Records of Natural Products. 2017;11(2):223-228.
16. Ortiz-Andrade RR, Rodriguez-Lopez V, Garduno-Ramirez ML, Castillo-Espana P, Estrada-Soto S. Anti-diabetic effect on alloxanized and normoglycemic rats and some pharmacological evaluations of Tournefortia hartwegiana. J Ethnopharmacol. 2005;101:37-42.
17. Preecha P, Thanchanok P, Udom K, Khonit S. Corchorusides A and B: New flavonol glycosides as α- glucosidase inhibitors from the leaves of Corchorus olitorius. Tetrahedron Lett. 2009;50:5864-5867.
18. Qamar FA, Afroz S, Feroz S, Siddiqui S, Ara A. Evaluation of hypoglycemic effect of Cassia italic. J Basic Appl Sci. 2011;7:61-64.
19. Sandeep K, Dilsher K, Shaival KR, Ravi KK. In vitro and in vivo aphrodisiac properties of C. depressus Linn. On rabbit corpus cavernosum smooth muscle relaxation and sexual behavior of normal male rats. J Ethnopharmacol. 2013;148:210-217.
20. Simonsen HT, Nordskjold JB, Smitt UW, Nyman U, Palpu P, Joshi P, et al. In vitro screening of Indian medicinal plants for anti- plasmodial activity. J Ethnopharmacol. 2001;74:195-204.
21. Tehseen G, Kalsoom A, Faiz HN, Muhammad AC. Screening of selected medicinal plants for urease inhibitory activity. Biol and Med. 2010;2(4):64-69.
22. Viqar UA, Akbar A, Zulfiqar A, Fehmida TB, Farah NZ. Cycloartane triterpeneglucosides from C. depressus. Phytochemistry. 1998;49(3):829-834.
23. Vohora SB, Shams MA, Khan MSY. Antipyretic and analgesic studies on the diacetate of a new triterpenic acid isolated from Corchorus depressus L. J Ethnopharmacol. 1981;4:223-228.
24. Yashwant KA, Nandakumar K, Handral M, Talwar S, Dhayabaran D. Hypoglycemic and anti-diabetic activity of stem bark extracts Erythrina indica in normal and alloxan-induced rats. Saudi Pharml J. 2011;19:35-42.